Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TAO Connect
company
About
A suite of online tools for client education, interaction, accountability, and progress assessment to facilitate effective treatment.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.36M
- Industries
- Health Care,Medical,Telecommunications
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
TAO Connect, Inc. is committed to reducing mental health disparities by bringing affordable, effective, and accessible treatment to people who have had limited access in the past.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$3.23M
TAO Connect has raised a total of
$3.23M
in funding over 2 rounds. Their latest funding was raised on
Jul 10, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 10, 2019 | Grant | $500K | 1 |
National Science Foundation
|
— | Detail |
| Sep 19, 2016 | Grant | $1.36M | 1 |
National Science Foundation
|
— | Detail |
| Feb 9, 2016 | Series A | $1.10M | 1 | — | — | Detail |
| Dec 18, 2014 | Grant | $269.99K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
2
TAO Connect is funded by 2 investors.
National Science Foundation
and Florida Angel Network
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Florida Angel Network
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
